MB

Matthew Bernett

XE Xencor: 12 patents #2 of 27Top 8%
AB AbbVie: 1 patents #75 of 245Top 35%
Overall (2020): #6,098 of 565,922Top 2%
12
Patents 2020

Issued Patents 2020

Patent #TitleCo-InventorsDate
10858451 Bispecific antibodies that bind to CD38 and CD3 Seung Chu, Gregory Moore, John Desjarlais 2020-12-08
10858417 Heterodimeric proteins Gregory Moore, Rumana Rashid, John Desjarlais 2020-12-08
10851178 Heterodimeric human IgG1 polypeptides with isoelectric point modifications Gregory Moore, John Desjarlais, Rumana Rashid 2020-12-01
10793632 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon 2020-10-06
10787518 Bispecific checkpoint inhibitor antibodies Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal 2020-09-29
10752678 Complement component C5 antibodies Peter C. Baciu, Yanbin Liang, Jason Guu, Umesh Muchhal, John Desjarlais 2020-08-25
10738133 Heterodimeric proteins Gregory Moore, Rumana Rashid, John Desjarlais 2020-08-11
10738132 Heterodimeric proteins John Desjarlais, Gregory Moore, Rumana Rashid 2020-08-11
10626182 Optimized antibodies that target CD19 Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more 2020-04-21
10550185 Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments Rumana Rashid, John Desjarlais, Rajat Varma, Christine Bonzon 2020-02-04
10544187 Targeting regulatory T cells with heterodimeric proteins Seung Chu, Dilki Wickramarachchi, John Desjarlais 2020-01-28
10526417 Heterodimeric antibodies that bind CD3 and CD38 Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal 2020-01-07